EPS for EXFO (EXFO) Expected At $0.05; Electromed (NYSEAMERICAN:ELMD) Shorts Lowered By 26.89%

March 21, 2018 - By Richard Conner

Analysts expect EXFO Inc (NASDAQ:EXFO) to report $0.05 EPS on April, 4.They anticipate $0.01 EPS change or 25.00% from last quarter’s $0.04 EPS. EXFO’s profit would be $2.76 million giving it 20.50 P/E if the $0.05 EPS is correct. After having $0.06 EPS previously, EXFO Inc’s analysts see -16.67% EPS growth. The stock decreased 1.20% or $0.05 during the last trading session, reaching $4.1. About 10,173 shares traded. EXFO Inc (NASDAQ:EXFO) has risen 19.54% since March 21, 2017 and is uptrending. It has outperformed by 2.84% the S&P500.

Electromed Inc (NYSEAMERICAN:ELMD) had a decrease of 26.89% in short interest. ELMD’s SI was 37,800 shares in March as released by FINRA. Its down 26.89% from 51,700 shares previously. With 16,000 avg volume, 2 days are for Electromed Inc (NYSEAMERICAN:ELMD)’s short sellers to cover ELMD’s short positions. The SI to Electromed Inc’s float is 0.8%. The stock increased 0.38% or $0.02 during the last trading session, reaching $5.23. About 15,401 shares traded or 18.69% up from the average. Electromed, Inc. (NYSEAMERICAN:ELMD) has risen 9.44% since March 21, 2017 and is uptrending. It has underperformed by 7.26% the S&P500.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company has market cap of $43.34 million. The firm offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It has a 22.84 P/E ratio. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device.

Since September 22, 2017, it had 0 buys, and 2 selling transactions for $295,918 activity. $261,365 worth of Electromed, Inc. (NYSEAMERICAN:ELMD) shares were sold by Red Oak Partners – LLC.

Investors sentiment increased to 2.83 in 2017 Q3. Its up 1.20, from 1.63 in 2017Q2. It is positive, as 5 investors sold Electromed, Inc. shares while 3 reduced holdings. 7 funds opened positions while 6 raised stakes. 1.88 million shares or 26.09% more from 1.49 million shares in 2017Q2 were reported. Morgan Stanley holds 0% or 296 shares in its portfolio. Tocqueville Asset L P has invested 0.03% in Electromed, Inc. (NYSEAMERICAN:ELMD). Acadian Asset Mngmt Limited invested in 2,939 shares or 0% of the stock. Teton Advsr Inc reported 106,654 shares or 0.07% of all its holdings. Eam Ltd Com stated it has 0.06% in Electromed, Inc. (NYSEAMERICAN:ELMD). Panagora Asset Mgmt Inc reported 0% in Electromed, Inc. (NYSEAMERICAN:ELMD). Blackrock accumulated 0% or 21,308 shares. Bridgeway Capital Management invested in 0.02% or 265,838 shares. Deutsche Retail Bank Ag accumulated 0% or 1,700 shares. Northern Trust reported 16,513 shares or 0% of all its holdings. Creative Planning accumulated 0% or 26,000 shares. Renaissance Technologies Ltd Liability Corporation has invested 0% of its portfolio in Electromed, Inc. (NYSEAMERICAN:ELMD). Carlson Capital Management invested in 14,134 shares. Spark Lc accumulated 65,176 shares. Dimensional Fund Advisors Lp owns 157,203 shares.

Among 6 analysts covering EXFO (NASDAQ:EXFO), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. EXFO had 17 analyst reports since September 9, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets on Thursday, October 12 with “Hold”. As per Sunday, October 15, the company rating was maintained by RBC Capital Markets. BMO Capital Markets maintained it with “Hold” rating and $5.5000 target in Thursday, June 29 report. The rating was maintained by Canaccord Genuity on Wednesday, August 9 with “Hold”. The firm earned “Hold” rating on Friday, October 13 by Canaccord Genuity. The rating was maintained by Northland Capital with “Buy” on Wednesday, October 11. The firm has “Hold” rating by RBC Capital Markets given on Friday, June 30. The stock of EXFO Inc (NASDAQ:EXFO) earned “Sector Perform” rating by National Bank Canada on Thursday, January 7. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, October 5. Northland Capital maintained the stock with “Buy” rating in Friday, June 30 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News